GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

WGS

Insider Sentiment (TTM):

Last Purchase:2026-06-05Last Sale:2026-06-16Shares Purchased (TTM):547,688Shares Sold (TTM):752,174

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:30,789,384Shares Outstanding:29,335,126Institutional Ownership Pct.:104.96%

Earnings Market Reaction:

Filing Date:2026-05-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Health Services

PRVA LFST USPH INNV PNTG TALK

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Nonrelated Party	-	-	-	-	-	37	13	-3	28	32	-1	33
Assets
Related Party	-	-	-	-	-	37	13	-3	28	32	-1	33
Assets Current
Cash And Cash Equivalents At Carrying Value	94	105	96	74	100	85	58	56	84	100	87	157
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	-	0
Marketable Securities Current	77	66	59	60	59	56	59	51	29	30	27	-
Accounts Receivable Net Current	77	74	61	48	46	38	-	-	-	-	-	-
Inventory Net	12	14	11	12	13	11	11	10	12	9	9	12
Prepaid Expense And Other Assets Current	11	9	11	10	8	9	20	19	10	11	16	11
Assets Current	271	268	238	205	226	198	186	162	163	182	172	213
Operating Lease Right Of Use Asset	35	23	24	25	25	26	25	26	26	27	28	34
Property Plant And Equipment And Finance Lease Rig…	50	46	42	40	36	33	31	31	31	32	36	43
Goodwill	2	14	13	13	-	0	-	-	-	-	-	-
Intangible Assets Net Excluding Goodwill	145	168	173	177	155	159	162	166	169	173	176	180
Restricted Cash Noncurrent	-	-	-	-	-	-	-	-	-	-	-	1
Other Assets Noncurrent	4	4	4	4	4	4	4	4	4	4	6	6
Assets	506	524	494	464	446	419	409	389	395	419	417	476
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	47	58	50	49	42	31	56	52	32	37	39	55
Other Liabilities Current	36	47	33	19	25	20	-	-	-	-	-	-
Liabilities Current	88	109	88	71	70	55	77	68	51	59	68	84
Long Term Debt Noncurrent	97	48	52	52	52	52	52	52	52	53	6	6
Other Liabilities Noncurrent	0	2	4	3	7	6	14	13	21	15	23	22
Deferred Income Tax Liabilities Net	1	1	1	1	1	1	1	1	1	2	2	2
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities	252	216	202	187	189	174	204	195	187	191	163	180
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,690	1,681	1,647	1,625	1,616	1,597	1,561	1,543	1,527	1,528	1,529	1,528
Retained Earnings Accumulated Deficit	-1,437	-1,373	-1,356	-1,348	-1,359	-1,352	-1,358	-1,350	-1,320	-1,300	-1,274	-1,232
Accumulated Other Comprehensive Income Loss Net Of…	1	1	1	1	1	1	1	0	0	0	-	-
Stockholders Equity	254	308	292	277	257	245	205	194	207	228	254	296
Liabilities And Stockholders Equity	506	524	494	464	446	419	409	389	395	419	417	476
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	30	29	29	29	29	28	27	27	26	26	26	26
Shares Outstanding	30	29	29	29	29	28	27	27	26	26	26	26

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-23.47%	2.78%	-13.00%	-	-	-	-	-	-	-	-	-
2025	7.11%	0.22%	16.48%	40.19%	41.21%	31.77%	6.61%	2.16%	-21.38%	-19.80%	-24.25%	-53.20%
2024	87.27%	149.64%	189.36%	18.69%	34.09%	99.30%	-6.32%	-7.88%	-17.31%	-3.06%	-4.87%	-41.78%
2023	-22.75%	-28.62%	-14.49%	-32.41%	-45.26%	-56.09%	-11.54%	63.74%	78.02%	52.41%	22.08%	163.32%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.09	2.46	2.71	2.87	3.25	3.61	2.41	2.38	3.22	3.10	2.51	2.53
Quick Ratio	2.83	2.26	2.47	2.56	2.95	3.26	2.00	1.95	2.80	2.77	2.15	2.26
Working Capital	182.99M	159.38M	149.96M	133.43M	156.28M	143.15M	108.67M	93.90M	112.69M	123.52M	103.45M	128.91M
Leverage & Debt
Debt to Equity	0.99	0.70	0.69	0.67	0.73	0.71	1.00	1.01	0.90	0.84	0.64	0.61
Interest Coverage TTM	-25.23	-5.15	3.67	1.81	-4.59	-7.66	-17.23	-26.10	-40.71	-52.21	-147.69	-175.78
Debt Ratio	0.50	0.41	0.41	0.40	0.42	0.42	0.50	0.50	0.47	0.46	0.39	0.38
Efficiency & Turnover
Asset Turnover TTM	0.93	0.91	0.89	0.85	0.79	0.73	0.65	0.56	0.47	0.45	0.33	0.34
Days Sales Outstanding TTM	50.67	47.81	55.30	48.38	50.84	44.97	-	-	-	-	-	-
Receivables Turnover TTM	7.20	7.63	6.60	7.54	7.18	8.12	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-2.65	-0.73	0.07	0.05	-1.37	-1.94	-3.08	-4.41	-5.18	-7.23	-17.79	-19.44
Free Cash Flow Per Share TTM	-0.98	0.50	0.54	0.03	-0.46	-1.26	-2.21	-3.62	-5.63	-7.63	-8.53	-10.59
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	69.56%	69.74%	69.65%	67.18%	65.26%	63.64%	59.48%	55.97%	50.57%	44.43%	20.79%	13.20%
Operating Profit Margin TTM	-14.91%	-3.06%	2.48%	1.50%	-4.27%	-7.60%	-21.58%	-38.11%	-60.35%	-89.15%	-232.37%	-223.19%
Net Profit Margin TTM	-17.58%	-4.92%	0.52%	0.39%	-11.68%	-17.12%	-31.25%	-48.21%	-60.86%	-86.77%	-222.16%	-208.96%
Growth Metrics
Net Revenue Growth (1Y)	34.09%	39.97%	50.50%	48.70%	48.81%	50.79%	29.41%	3.06%	-0.91%	-13.69%	-10.66%	23.73%
Net Income Growth (1Y)	101.70%	-59.80%	-102.49%	-101.20%	-71.43%	-70.25%	-81.80%	-76.22%	-74.67%	-67.98%	63.61%	190.46%
EPS Growth (1Y)	93.54%	-62.25%	-102.35%	-101.11%	-73.55%	-73.11%	-82.68%	-77.29%	-80.50%	-73.04%	46.40%	133.91%
Valuation Metrics
P/E TTM	-24.21	-177.21	1,489.52	1,876.38	-64.62	-39.53	-13.77	-5.92	-1.76	-0.38	-0.20	-0.31
P/B TTM	7.41	12.09	10.62	9.52	9.68	8.43	5.62	3.59	1.15	0.29	0.37	0.51
P/S TTM	4.26	8.71	7.71	7.28	7.55	6.77	4.30	2.86	1.07	0.33	0.45	0.64
Market Cap	1.88B	3.73B	3.10B	2.64B	2.49B	2.07B	1.15B	695.79M	237.95M	66.86M	93.87M	151.49M
Enterprise Value	1.89B	3.67B	3.06B	2.61B	2.44B	2.03B	1.14B	690.89M	205.58M	18.88M	11.64M	188.41K
Calculated Values
Free Cash Flow TTM	-28.65M	14.26M	15.47M	830.00K	-13.08M	-33.99M	-59.99M	-96.29M	-146.69M	-185.40M	-219.98M	-269.25M
Net Debt	1.82M	-57.81M	-45.38M	-23.43M	-48.90M	-34.29M	-6.85M	-4.90M	-32.37M	-47.98M	-82.24M	-151.31M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-16Sale

Owner: Stueland, Katherine

Title: CHIEF EXECUTIVE OFFICER

Shares: 10,501

Price/Share: $60.69

Value: $637,305.69

Shares Owned: 104,372

Relationship: Director,Officer

Ownership: Direct

2026-06-16Sale

Owner: Feeley, Kevin

Title: CHIEF FINANCIAL OFFICER

Shares: 3,729

Price/Share: $60.69

Value: $226,313.01

Shares Owned: 39,954

Relationship: Officer

Ownership: Direct

2026-06-09Sale

Owner: Stueland, Katherine

Title: CHIEF EXECUTIVE OFFICER

Shares: 3,639

Price/Share: $53.77

Value: $195,669.03

Shares Owned: 96,123

Relationship: Director,Officer

Ownership: Direct

2026-06-09Sale

Owner: Feeley, Kevin

Title: CHIEF FINANCIAL OFFICER

Shares: 1,266

Price/Share: $53.77

Value: $68,072.82

Shares Owned: 36,486

Relationship: Officer

Ownership: Direct

2026-06-05Purchase

Owner: Casdin, Eli, Casdin Partn…

Title: -

Shares: 50,000

Price/Share: $52.86

Value: $2,643,000.00

Shares Owned: 3,707,164

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-16	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	10,501	60.69	$637,305.69	104,372	4
2026-06-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,729	60.69	$226,313.01	39,954	4
2026-06-09	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,639	53.77	$195,669.03	96,123	4
2026-06-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,266	53.77	$68,072.82	36,486	4
2026-06-05	Casdin, Eli, Casdin Partn…	Director,TenPercentOwner	-	Indirect	Purchase	50,000	52.86	$2,643,000.00	3,707,164	4
2026-06-01	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	369	51.74	$19,092.06	35,290	4
2026-05-20	Casdin, Partners Master F…	Director,TenPercentOwner	-	Indirect	Purchase	140,000	43.81	$6,133,400.00	3,507,164	4
2026-05-15	Meister, Keith A., Corvex…	Director,TenPercentOwner	-	Indirect	Purchase	46,273	39.06	$1,807,423.38	4,784,570	4
2026-05-08	Meister, Keith A., Corvex…	Director,TenPercentOwner	-	Indirect	Purchase	171,389	39.63	$6,792,146.07	3,933,297	4
2026-04-29	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,172	64.66	$140,441.52	93,216	4
2026-04-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	392	65.19	$25,554.48	34,942	4
2026-03-26	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	46,933	63.34	$2,972,736.22	91,514	4
2026-03-26	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,818	63.34	$558,532.12	34,580	4
2026-03-16	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	17,179	77.11	$1,324,672.69	58,447	4
2026-03-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	5,706	77.11	$439,989.66	27,148	4
2026-03-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,280	86.75	$111,040.00	21,842	4
2026-03-09	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,678	86.75	$319,066.50	44,955	4
2026-03-05	Meister, Keith A., Corvex…	Director,TenPercentOwner	-	Indirect	Purchase	140,026	80.17	$11,225,884.42	3,228,150	4
2026-03-04	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	6,187	78.50	$485,679.50	18,674	4
2026-03-04	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	25,459	78.50	$1,998,531.50	38,683	4
2026-03-02	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	287	77.52	$22,248.24	9,599	4
2026-02-04	Dechairo, Bryan	Officer	Chief Operating Officer	Direct	Sale	5,961	87.10	$519,203.10	0	4
2026-02-02	Dechairo, Bryan	Officer	Chief Operating Officer	Direct	Sale	3,413	98.77	$337,102.01	5,961	4
2026-01-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	317	93.03	$29,490.51	9,168	4
2026-01-29	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	1,653	94.00	$155,382.00	16,458	4
2025-12-16	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	10,857	144.39	$1,567,642.23	14,237	4
2025-12-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,855	144.35	$556,469.25	8,731	4
2025-12-09	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,639	159.28	$579,619.92	6,344	4
2025-12-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,266	159.28	$201,648.48	5,389	4
2025-12-01	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	377	162.54	$61,277.58	4,193	4
2025-11-24	Ruch, Joshua	Director	-	Indirect	Sale	38,000	160.27	$6,090,260.00	11,941	4
2025-10-29	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,158	136.64	$294,869.12	3,436	4
2025-10-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	388	136.54	$52,977.52	3,757	4
2025-09-30	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	12,858	109.10	$1,402,807.80	1,720	4
2025-09-30	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	6,609	109.16	$721,438.44	3,392	4
2025-09-16	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	10,501	121.47	$1,275,556.47	14,578	4
2025-09-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,728	121.47	$452,840.16	8,755	4
2025-09-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,657	128.56	$470,143.92	6,329	4
2025-09-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,272	128.57	$163,541.04	5,286	4
2025-09-02	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	378	125.81	$47,556.18	4,096	4
2025-08-27	Ryan, Jason	Director	-	Direct	Sale	1,150	129.65	$149,097.50	11,904	4
2025-08-22	Casdin, Eli, Casdin Partn…	Director,TenPercentOwner	-	Indirect	Sale	500,000	120.90	$60,450,000.00	3,007,164	4
2025-07-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	388	105.31	$40,860.28	3,757	4
2025-07-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,154	105.31	$226,837.74	3,440	4
2025-07-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	5,278	93.00	$490,854.00	3,392	4
2025-07-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,220	93.00	$299,460.00	1,720	4
2025-07-01	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,344	91.37	$122,801.28	7,425	4
2025-07-01	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	9,657	91.56	$884,194.92	4,940	4
2025-06-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,729	64.77	$241,527.33	8,769	4
2025-06-16	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	10,501	64.77	$680,149.77	14,597	4
2025-06-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,266	72.55	$91,848.30	5,301	4
2025-06-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,639	72.55	$264,009.45	6,348	4
2025-06-02	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	370	71.26	$26,366.20	4,105	4
2025-05-14	Corvex, Management Lp, Me…	Director,TenPercentOwner	-	Indirect	Purchase	50,000	60.17	$3,008,500.00	3,058,629	4
2025-05-08	Meister, Keith A., Corvex…	Director,TenPercentOwner	-	Indirect	Purchase	100,000	56.73	$5,673,000.00	3,008,629	4
2025-04-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	388	113.09	$43,878.92	3,337	4
2025-04-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,154	113.09	$243,595.86	3,440	4
2025-04-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	14,270	90.85	$1,296,429.50	2,972	4/A
2025-04-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	46,594	89.33	$4,162,242.02	1,720	4
2025-03-26	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,746	95.03	$831,132.38	15,996	4
2025-03-26	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	46,551	95.12	$4,427,931.12	48,314	4
2025-03-17	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	10,559	96.71	$1,021,160.89	14,865	4
2025-03-17	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,749	96.71	$362,565.79	8,492	4
2025-03-10	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	922	94.72	$87,331.84	5,446	4
2025-03-10	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,731	94.73	$258,707.63	7,752	4
2025-03-03	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	261	103.94	$27,128.34	3,906	4
2025-01-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	1,657	78.48	$130,041.36	3,937	4
2025-01-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	275	78.48	$21,582.00	2,950	4
2025-01-07	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	51,420	94.89	$4,879,243.80	1,720	4
2025-01-07	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	35,506	94.94	$3,370,939.64	2,472	4
2025-01-02	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,430	76.04	$108,737.20	26,770	4
2025-01-02	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	18,006	78.10	$1,406,268.60	53,140	4
2024-12-16	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	10,501	76.75	$805,951.75	71,146	4
2024-12-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,728	76.75	$286,124.00	28,200	4
2024-12-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,661	76.37	$279,590.57	62,897	4
2024-12-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,137	76.37	$86,832.69	24,731	4
2024-12-02	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	263	78.39	$20,616.57	23,406	4
2024-11-22	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	9,981	76.38	$762,348.78	22,951	4
2024-11-20	Ryan, Jason	Director	-	Indirect	Sale	15,490	69.57	$1,077,639.30	0	4
2024-11-18	Icahn, School Of Medicine…	TenPercentOwner	-	Direct	Sale	126,782	70.78	$8,973,629.96	2,719,692	4
2024-11-18	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	22,307	69.40	$1,548,105.80	60,011	4
2024-10-31	Icahn, School Of Medicine…	TenPercentOwner	-	Direct	Sale	865,800	75.00	$64,935,000.00	2,866,833	4
2024-10-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,154	66.60	$143,456.40	105,426	4
2024-10-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	274	66.60	$18,248.40	44,951	4
2024-09-16	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	10,501	37.59	$394,732.59	103,706	4
2024-09-16	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,635	37.59	$99,049.65	44,472	4
2024-09-09	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,639	33.33	$121,287.87	95,457	4
2024-09-09	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	895	33.33	$29,830.35	39,910	4
2024-09-03	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	262	31.71	$8,308.02	38,343	4
2024-08-19	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	50,000	34.49	$1,724,500.00	2,646,972	4
2024-08-13	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	24,987	34.76	$868,548.12	2,786,796	4
2024-08-08	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	100,000	31.82	$3,182,000.00	2,871,570	4
2024-07-31	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	88,839	33.50	$2,976,106.50	2,984,564	4
2024-07-29	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	50,000	33.86	$1,693,000.00	3,073,403	4
2024-07-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,154	33.54	$72,245.16	92,550	4
2024-07-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	274	33.54	$9,189.96	37,888	4
2024-07-26	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	60,000	33.85	$2,031,000.00	3,123,403	4
2024-07-23	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	75,000	33.46	$2,509,500.00	3,258,403	4
2024-07-17	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	25,000	32.93	$823,250.00	3,408,403	4
2024-07-05	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	36,118	28.24	$1,019,972.32	3,433,403	4
2024-07-03	Opko, Health, Inc.	TenPercentOwner	-	Direct	Sale	14,082	28.23	$397,534.86	3,469,521	4
2024-06-17	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	7,683	28.31	$217,505.73	90,830	4
2024-06-17	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,646	28.31	$74,908.26	37,409	4
2024-06-10	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,652	24.92	$66,087.84	79,763	4
2024-06-10	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	895	24.92	$22,303.40	32,858	4
2024-06-04	Casdin, Capital, Llc, Cas…	Director,TenPercentOwner	-	Direct	Purchase	30,000	22.52	$675,600.00	3,093,509	4
2024-06-03	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	262	20.55	$5,384.10	31,291	4
2024-05-29	Casdin, Eli, Casdin Capit…	Director,TenPercentOwner	-	Direct	Purchase	40,000	21.07	$842,800.00	2,963,509	4
2024-05-28	Casdin, Eli, Casdin Partn…	Director,TenPercentOwner	-	Direct	Purchase	18,304	20.61	$377,245.44	2,923,509	4
2024-05-13	Casdin, Capital, Llc, Cas…	Director,TenPercentOwner	-	Direct	Purchase	50,000	23.31	$1,165,500.00	2,753,509	4
2024-04-29	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	6,325	11.04	$69,828.00	75,869	4
2024-04-29	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,104	11.04	$12,188.16	30,836	4
2024-03-18	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	8,559	10.59	$90,639.81	66,698	4
2024-03-18	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	3,253	10.59	$34,449.27	28,927	4
2024-03-18	Saad, Kareem	Officer	CHIEF TRANSFORMATION OFFICER	Direct	Sale	2,008	10.59	$21,264.72	29,517	4
2024-03-12	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	931	9.21	$8,574.51	24,983	4
2024-03-12	Stueland, Katherine	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,618	9.21	$24,111.78	56,507	4
2024-03-12	Saad, Kareem	Officer	CHIEF TRANSFORMATION OFFICER	Direct	Sale	897	9.21	$8,261.37	26,411	4
2024-03-05	Casdin, Partners Master F…	Director	-	Direct	Purchase	900	8.83	$7,947.00	2,703,509	4
2024-03-04	Feeley, Kevin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	301	8.57	$2,579.57	23,452	4
2024-01-22	Saad, Kareem	Officer	CHIEF TRANSFORMATION OFFICER	Direct	Sale	193	3.24	$625.32	24,467	4
2024-01-03	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	105	2.58	$270.90	24,114	4
2023-12-18	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	1,700	2.16	$3,672.00	23,946	4
2023-12-18	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	2,948	2.16	$6,367.68	23,035	4
2023-12-18	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	11,734	2.16	$25,345.44	52,578	4
2023-12-11	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	908	1.61	$1,461.88	18,786	4
2023-12-11	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	850	1.61	$1,368.50	20,532	4
2023-12-11	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	3,673	1.61	$5,913.53	45,562	4
2023-12-04	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	270	1.77	$477.90	17,232	4
2023-11-17	Ryan, Jason	Director,Officer	Executive Chairman	Indirect	Purchase	58,000	1.54	$89,320.00	114,742	4
2023-11-15	Meister, Keith A., Corvex…	TenPercentOwner	-	Indirect	Sale	883,742	1.29	$1,140,027.18	3,011,066	4
2023-11-08	Pfenniger, Richard C Jr	Director	-	Direct	Purchase	10,000	1.49	$14,900.00	20,918	4
2023-10-20	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	164	3.44	$564.16	18,541	4
2023-10-17	Ryan, Jason	Director,Officer	Executive Chairman	Direct	Sale	42	3.19	$133.98	5,834	4
2023-10-03	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	85	3.56	$302.60	18,159	4
2023-09-18	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	1,580	4.16	$6,572.80	17,971	4
2023-09-18	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	2,742	4.16	$11,406.72	16,785	4
2023-09-18	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	10,752	4.16	$44,728.32	42,689	4
2023-09-11	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	2,675	4.62	$12,358.50	34,691	4
2023-09-11	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	904	4.62	$4,176.48	12,330	4
2023-09-11	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	846	4.62	$3,908.52	14,437	4
2023-09-05	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	269	4.38	$1,178.22	10,772	4
2023-08-17	Pfenniger, Richard C Jr	Director	-	Direct	Purchase	5,000	5.10	$25,500.00	10,918	4
2023-07-26	White, Karen Ann	Officer	Chief People Officer	Direct	Sale	61	7.41	$452.01	4,761	4
2023-07-20	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	163	7.85	$1,279.55	12,442	4
2023-07-03	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	83	5.99	$497.17	12,059	4
2023-07-03	White, Karen Ann	Officer	Chief People Officer	Direct	Sale	45	5.99	$269.55	4,685	4
2023-06-20	Saad, Kareem	Officer	Chief Transformation Officer	Direct	Sale	1,221	6.34	$7,741.14	11,869	4
2023-06-20	Stueland, Katherine	Director,Officer	Chief Executive Officer	Direct	Sale	7,965	6.35	$50,577.75	30,819	4
2023-06-20	White, Karen Ann	Officer	Chief People Officer	Direct	Sale	1,549	6.35	$9,836.15	4,631	4
2023-06-20	Feeley, Kevin	Officer	Chief Financial Officer	Direct	Sale	2,744	6.34	$17,396.96	10,324	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

104.96%

Inst. Shares: 30,789,384

Shares Outstanding: 29,335,126

2025-12-31

102.18%

Inst. Shares: 29,265,826

Shares Outstanding: 28,641,734

2025-09-30

98.37%

Inst. Shares: 28,327,748

Shares Outstanding: 28,797,730

2025-06-30

103.97%

Inst. Shares: 29,714,462

Shares Outstanding: 28,579,704

2025-03-31

96.11%

Inst. Shares: 27,051,613

Shares Outstanding: 28,147,948

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	30,789,384	29,335,126	104.96%
2025-12-31	29,265,826	28,641,734	102.18%
2025-09-30	28,327,748	28,797,730	98.37%
2025-06-30	29,714,462	28,579,704	103.97%
2025-03-31	27,051,613	28,147,948	96.11%
2024-12-31	22,411,725	26,891,213	83.34%
2024-09-30	18,503,251	27,095,986	68.29%
2024-06-30	16,121,340	26,617,955	60.57%
2024-03-31	13,825,579	26,062,170	53.05%
2023-12-31	12,334,841	24,311,989	50.74%
2023-09-30	13,797,742	25,788,747	53.50%
2023-06-30	13,909,584	25,418,358	54.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

GeneDx Holdings Corp. (WGS) — SEC Financial Statements & Analysis

GeneDx Holdings Corp. (WGS) is a services-health services company, incorporated in DE. GeneDx Holdings Corp. trades on Nasdaq as: WGS, WGSWW. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), GeneDx Holdings Corp. reported a 34.09% year-over-year revenue growth, a Gross Profit Margin of 69.56% (TTM), a Debt-to-Equity ratio of 0.99x, a Price-to-Sales (P/S) ratio of 4.26x (TTM), a Price-to-Book (P/B) ratio of 7.41 (TTM), at a market cap of $1.88B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 34.09%
Gross Profit Margin TTM: 69.56%
Debt To Equity: 0.99x
P/S TTM: 4.26x
P/B TTM: 7.41
Market Cap: $1.88B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GeneDx Holdings Corp. in?

GeneDx Holdings Corp. (WGS) operates in the Services-Health Services industry.

What is WGS's market cap?

GeneDx Holdings Corp. (WGS) has a market capitalization of $1.88B as of 2026-03-31.

What exchange does WGS trade on?

GeneDx Holdings Corp. (WGS) trades on the Nasdaq.

Where is GeneDx Holdings Corp. incorporated?

GeneDx Holdings Corp. is incorporated in DE.

GeneDx Holdings Corp. (WGS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.